Turn Therapeutics Inc. TTRX
10.66 USD +0.74 (+7.46%)
Nov 11, 2026, 3:03 PM EST
10.11 Day range 11.18
2.57 52-week range 16.45
- YTD
- +170.57%
- 1 year
- +174.76%
- Market cap
- 325.24M
- EPS (ttm)
- -0.43
- YTD return
- +170.57%
- 1-year return
- +174.76%
- Volume
- 27.77K
- Avg volume
- 113.00K
- Open
- 10.11
- Previous close
- 9.92
- Day's range
- 10.11 – 11.18
- 52-week range
- 2.57 – 16.45
5D +0.15 (+1.54%)
Financials — quick view
TTRX Revenue — quarterly 0
TTRX Net income — quarterly -6.23M
TTRX EPS — quarterly -0.21
News
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results 
Turn Therapeutics Q3 EPS $(0.21) Misses $(0.09) Estimate 
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results 
Turn Therapeutics' GX-03 Earns “Developmental Immunology Solution of the Year” in 2026 BioTech Breakthrough Awards Program 
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday 
This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday 
WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10 
This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - LUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24
WBB Securities Downgrades Turn Therapeutics to Sell, Announces $10 Price Target
Your note
Sign in to keep a note on TTRX — it syncs with the Stock Master app.